Established cancer drug can reactivate immunotherapy
Genetically modified immune cells can offer precious additional time to patients with advanced multiple myeloma. However, these therapies lose their impact as the molecules on cancer cells that immune cells recognize gradually ...
47 minutes ago
0
0









